Masimo shareholders today will decide on a bitter proxy fight between the company's founder and CEO Joe Kiani and Politan ...

Founder Joe Kiani has led Masimo for 35 years. But he says he'll quit if he loses this week's proxy vote to Politan Capital.

"We are united in our enthusiasm for Masimo’s future as a leading, innovation-focused growth company," the newest board ...

Joe Kiani, founder of a company that he built into billions of dollars of sales, was ousted from the board, according to an ...

The Company has 4,000 patents, including 900 that bear Joe Kiani’s name ... stockholder value and lifesaving and life-improving technologies. In fact, Masimo has doubled its non-GAAP earnings ...

A Sept. 19 proxy vote by Masimo (Nasdaq: MASI) shareholders has the potential to end the tenure of co-founder and CEO Joe Kiani and bring about an unprecedented amount of change to the Irvine device ...

In summarizing its position, Egan-Jones stated: “Joe Kiani’s track record in driving innovation and securing IP rights is critical to Masimo’s future success.” “A dissident win could ...

The Company urges stockholders to vote “FOR” Masimo’s director nominees, Joe Kiani and Christopher Chavez, on the updated GOLD proxy card to protect Masimo’s future and your investment.

This builds on the continued momentum we are driving across Masimo, as demonstrated by our strong second quarter results and recently announced strategic partnerships with companies such as Google and ...

In summarizing its position, Egan-Jones stated: “Joe Kiani’s track record in driving ... Our mission is to improve life, improve patient outcomes, and reduce the cost of care.